Search results

ITRAX has now analysed more than a kilometre of cores since it became operational in 2012.

Collaboration investigates a promising new nanoparticle for potential use in combination with other therapies for brain cancer

Research has revealed the Lapita cultural group interacted with the indigenous people of Papua New Guinea more than 3,000 years ago and set the stage for the peopling of the Pacific

Research represents significant step towards developing vaccine

ANSTO researchers have taken up the challenge to develop a coating for the cladding used in nuclear reactors to prevent it from taking up hydrogen and releasing it if temperatures get too high and repair itself if damaged.

The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.

ANSTO has contributed to a recent publication in Nature Communications Biology that represents a landmark achievement in structural biology, an understanding of protein regulation mechanisms in Mycobacterium tuberculosis (Mtb), a global health threat.

Research undertaken by Flinders University, the University of Cincinnati (US), Guangzhou University (China) and ANSTO has evaluated a new process to encapsulate fish oil in nanoparticles

ANSTO in consultation with partners has developed a specialised training course to support first responder agencies in ensuring personnel are effectively prepared for response to radiological and nuclear emergency situations.

ANSTO recognised the contribution of individuals and teams to nuclear science and technology at the 2023 ANSTO Awards Ceremony held on 25 July.

Publications by ANSTO's National Deuteration Facility.

Publications and resources from the Powder Diffraction beamline.